Fig 1: Unique protein profile and functional identification of EV isolated from sham and IRI kidneys.(A–C) Identification of EV by electron microscopy (A), nanoparticle tracking analysis (NTA) (B), and Western blotting (C). (D) Volcano plot showing the differential protein expression of IRI-EV compared with sham-EV. (E) Heatmap showing cluster analysis of differentially expressed proteins in EV isolated from sham versus IRI kidneys. (F) KEGG pathway analysis of differential proteins in EV. (G) Heatmap showing the typical molecules involved in extracellular matrix–receptor (ECM-receptor) interactions. (H) Cell internalization of Dil-labeled EV (red). (I) Detection of cell migration ability after stimulation with sham-EV and IRI-EV. (J) The expression of CD86, Tnfa, Il1b, and Ccl2 detected by PCR after MPs had taken up tissue-derived EV. n = 3–4. Data are expressed as the mean ± SD. One-way ANOVA was used for comparisons of 3 or more groups. *P < 0.05, **P < 0.01. Scale bars: 50 μm (H) and 100 μm (I).
Fig 2: Effects of SP-D overexpression on the gene expression profile of chondrocytes. (A) Chondrocytes were co-treated by lipofectamine transfected pcDNA3.1 empty plasmid and pcDNA3.1-SP-D plasmid (1 μg/μL). The protein expression of SP-D was assessed via western blotting. (B) The clustering analysis of samples showed high similarity, which confirmed the correctness of the experimental design and sample sampling. (C) The heat map showed that the gene expression patterns and clustering relationships of the samples were similar. (D) Comparisons between samples showed the number of differentially expressed genes. (E, F) GO analysis showed that the biological processes such as regulation of ‘inflammatory responses’, ‘immune response’ and ‘response to LPS’ were associated with SP-D in chondrocytes. (G, H) KEGG pathway analyses revealed these genes to be significantly linked to pathways including the ‘PI3K-Akt signaling pathway’, ‘ECM-receptor interaction’, ‘TLR signaling pathway’, and ‘TNF signaling pathway’.
Fig 3: Analysis of inflammation in left ventricles lysates; immunoblot quantification of NLRP3 (a), caspase-1/procaspase-1 ratio (b), IL-1 β/proIL-1β ratio (c), TNF (d); representative immunoblots and total protein staining (e). Data are presented as mean ± SEM; * p < 0.05. 2WA—two-way ANOVA; “Ischemia”—presence of ischemia/reperfusion; “Treatment”—presence of GSK’872.
Fig 4: Analysis of TNF expression and its correlation with the main necroptotic markers in the RV tissue. Relative protein expression (A) and representative immunoblots and total protein staining (E) of TNF in control group, monocrotaline group (MCT) and prematurely terminated monocrotaline group (ptMCT). Correlation between TNF and pThr231/Ser232‐RIP3 (B), pSer345‐MLKL (C), RIP3 (D) in monocrotaline group (MCT) and prematurely terminated monocrotaline group (ptMCT). Data are presented as mean ± SEM; n = 9–10 per group; * p ˂ 0.05; n.s.—non‐significant
Fig 5: Intrathecal injection of TNF antagonist etanercept reduces carrageenan-induced spinal JNK1/2 activation. Bar graphs depicting percent (%) change of (A) p-JNK1 and (B) p-JNK2 in the lumbar ipsilateral spinal cord 1 h after carrageenan injection in the presence of i.t. etanercept (100 μg), compared with vehicle (saline) injected control rats. Representative western blot images showing immunopositive bands from spinal cord homogenates for p-JNK1/2, total JNK1/2 (t-JNK1/2) and β-actin (loading control). All data are presented as mean ± SEM, **p < 0.01; ***p < 0.001, versus vehicle controls.
Supplier Page from Abcam for Anti-TNF alpha antibody